摘要
简介:使用CRISPR / Cas9的基因组编辑在其范围,多功能性和易用性方面进展非常迅速。斑马鱼(Danio rerio)一直是脊椎动物模型物种之一,其中CRISPR / Cas9已被非常广泛地应用于许多不同的目的并取得巨大成功。具体而言,斑马鱼中的疾病模型对于测试特定基因变体在临床前环境中的致病性是有用的。在这里,我们介绍可以改善斑马鱼基因组编辑的不同物种和系统的多项进展。 目的:为了实现基因组编辑的时空精度,许多新技术可应用于斑马鱼中,如人工转录因子,药物诱导或光遗传驱动的Cas9表达,或Cas9的化学诱导活化。此外,死Cas9(催化失活,dCas9)的化学或光遗传诱导重建可以实现基因调控的时空控制。除了控制基因组编辑发生的地点和时间之外,使用寡核苷酸允许引入(敲入)基因组的精确修饰。 结论:我们回顾了最近的趋势,以提高基于寡核苷酸的点突变敲入的精度和效率,并讨论这些改进如何应用于斑马鱼的工作。与化学诱变如何使斑马鱼中的第一个遗传屏幕相类似,多重化的sgRNA文库和Cas9可以使得在该物种中进行遗传筛选的下一个革命性转变成为可能。我们讨论使用sgRNAs作为特异性和有效诱变剂的方法的第一个例子和前景。此外,我们已经审查了方法,旨在测量单个细胞的表型后,其编码个别sgRNAs载体诱变摄动。这些方法可以从不同的基于细胞的报告基因到单细胞RNA测序,并且可以作为高通量遗传筛选的重要工具。
关键词: CRISPR,Cas9,sgRNA,斑马鱼,基因筛选,单细胞RNA测序
Current Gene Therapy
Title:New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish
Volume: 17 Issue: 4
关键词: CRISPR,Cas9,sgRNA,斑马鱼,基因筛选,单细胞RNA测序
摘要: Introduction: Genome editing using CRISPR/Cas9 has advanced very rapidly in its scope, versatility and ease of use. Zebrafish (Danio rerio) has been one of the vertebrate model species where CRISPR/Cas9 has been applied very extensively for many different purposes and with great success. In particular, disease modeling in zebrafish is useful for testing specific gene variants for pathogenicity in a preclinical setting. Here we describe multiple advances in diverse species and systems that can improve genome editing in zebrafish.
Objective: To achieve temporal and spatial precision of genome editing, many new technologies can be applied in zebrafish such as artificial transcription factors, drug-inducible or optogenetically-driven expression of Cas9, or chemically-inducible activation of Cas9. Moreover, chemically- or optogenetically- inducible reconstitution of dead Cas9 (catalytically inactive, dCas9) can enable spatiotemporal control of gene regulation. In addition to controlling where and when genome editing occurs, using oligonucleotides allows for the introduction (knock-in) of precise modifications of the genome.
Conclusion: We review recent trends to improve the precision and efficiency of oligo-based point mutation knock-ins and discuss how these improvements can apply to work in zebrafish. Similarly to how chemical mutagenesis enabled the first genetic screens in zebrafish, multiplexed sgRNA libraries and Cas9 can enable the next revolutionary transition in how genetic screens are performed in this species. We discuss the first examples and prospects of approaches using sgRNAs as specific and effective mutagens. Moreover, we have reviewed methods aimed at measuring the phenotypes of single cells after their mutagenic perturbation with vectors encoding individual sgRNAs. These methods can range from different cell-based reporters to single-cell RNA sequencing and can serve as great tools for high-throughput genetic screens.
Export Options
About this article
Cite this article as:
New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish, Current Gene Therapy 2017; 17 (4) . https://dx.doi.org/10.2174/1566523217666171121164132
DOI https://dx.doi.org/10.2174/1566523217666171121164132 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements